the FDA isnt supposed to "buy into" anything...its

the FDA isnt supposed to "buy into" anything...its the job of a TRIAL to determine if anything is legitimate and has legs when pre clinical data suggests so. its not the job of the FDA to make sure it has NO CHANCE of success whatsoever.

and of course they DID see improvement "by then" at 2 weeks, and of course we know it DID work at 2 weeks. of course until the following 2 weeks when the patients crashed - after being denied leronilmab. not sure if this has ever happened in the history of clinical trials where the dosing was throttled and cut in half against the wishes of the actual people who would know better. total setup trap and horrifically obvious. decided by G men. literally.

also if the FDA didnt "buy" the immunomodulation of leronlimab, why grant a trial at all? they decided to give it a half baked trial instead? this never made sense to me. if that was the thinking - lets see what 2 weeks will do - and 2 weeks looked really good - then why did they not acknowledge this? because they got to say the numbers at 4 weeks were not
of statistical significance...FDA =1 CYDY=0

now go away

yay!

the lunacy is maddening. i can only expect more.